Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has submitted a certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. This is a routine regulatory compliance filing, typically related to share dematerialization or depository-related confirmations. No specific financial figures or material corporate action details are mentioned in the disclosure. The filing indicates the company is meeting its ongoing regulatory obligations with SEBI and the exchange.
This is a standard compliance disclosure with no direct impact on business operations, financials, or stock price. Investors can view it as a routine regulatory update confirming the company remains in good standing with depository regulations.